MONDAY, May 19, 2025 (HealthDay News) — Artificial intelligence (AI) can help detect when a person’s multiple sclerosis (MS) has reached an advanced state, a new study says. A newly developed AI correctly judged with 90% accuracy when a person’s MS had transitioned to a stage where it will progressContinue Reading
WEDNESDAY, April 9, 2025 (HealthDay News) — An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondaryContinue Reading
WEDNESDAY, Feb. 26, 2025 (HealthDay News) — A diet rich in fish might slow the progression of multiple sclerosis in some patients, a new study says. The nutrients found in fish can quell inflammation and protect brain cells, and this might be of particular benefit for MS patients, researchers reportedContinue Reading
THURSDAY, Feb. 13, 2025 (HealthDay News) — Children who develop multiple sclerosis appear to fare better if they were exposed to safe amounts of summer sunshine as infants, new research shows. If their moms got some summer sun while pregnant, that seemed to help, too, according to a study publishedContinue Reading
FRIDAY, Dec. 27, 2024 (HealthDay News) — People with multiple sclerosis (MS) have been concerned that a COVID-19 infection could cause the symptoms of their nerve disease to become even worse. But a new study should offer some solace — COVID doesn’t appear to worsen MS, researchers reported Dec. 23,Continue Reading
WEDNESDAY, Dec. 11, 2024 (HealthDay News) — For children genetically predisposed to develop multiple sclerosis (MS), exposure to cigarette smoke in the family home could raise that risk even higher, new research shows. “A higher genetic MS risk is associated with an increased vulnerability to the negative effects of householdContinue Reading
FRIDAY, Nov. 29, 2024 (HealthDay News) — A child from a poorer neighborhood is more prone to severe illness once they develop multiple sclerosis (MS) compared to children growing up in more affluent areas, new research shows. The study of 138 MS patients who’d been diagnosed before the age ofContinue Reading
THURSDAY, Oct. 31, 2024 (HealthDay News) — A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report finds. Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson’s and Alzheimer’sContinue Reading
FRIDAY, Oct. 25, 2024 (HealthDay News) — Medication and behavioral therapy are both effective in combatting fatigue caused by multiple sclerosis (MS), either separately or together, a new study finds. MS patients felt significantly less fatigue after they were prescribed modafinil (Provigil), a drug that promotes wakefulness and is usedContinue Reading
THURSDAY, Oct. 10, 2024b (HealthDay News) — There’s a small but significant increased of certain cancers in people battling multiple sclerosis (MS), new research shows. Those malignancies include cancers of the bladder, brain and cervix, said a team from Rennes University in France. “People with MS undergo an increased numberContinue Reading
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — Two key symptoms that can arise soon after a diagnosis of multiple sclerosis (MS) could predict how swiftly the illness will progress and suggest best treatment options, new research shows. The two symptoms — blurred vision and sphincter dysfunction of the bladder and/orContinue Reading
WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds. Such treatment could prevent or potentially cure paramagnetic rim lesions (PRL), areas of chronic brain inflammation that are linked to moreContinue Reading
TUESDAY, Aug. 27, 2024 (HealthDay News) — People with multiple sclerosis appear to have a lower risk of developing Alzheimer’s disease, a new study suggests. MS patients are far less likely to have elevated blood levels of toxic proteins that form amyloid plaques in the brains of people with Alzheimer’s,Continue Reading
WEDNESDAY, Aug. 21, 2024 (HealthDay News) — Multiple sclerosis makes people vulnerable to more severe cases of COVID-19, but a new study finds that getting the COVID vaccine won’t trigger a relapse of MS symptoms. “People with MS have an increased risk of severe COVID infection due to their levelContinue Reading